Financhill
Sell
36

DPSTF Quote, Financials, Valuation and Earnings

Last price:
$35.46
Seasonality move :
-2.63%
Day range:
$34.41 - $35.46
52-week range:
$34.41 - $50.38
Dividend yield:
5.61%
P/E ratio:
12.16x
P/S ratio:
0.47x
P/B ratio:
1.67x
Volume:
2.2K
Avg. volume:
3K
1-year change:
-27.9%
Market cap:
$41.4B
Revenue:
$88.5B
EPS (TTM):
$2.92
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $70.9B $76.2B $96.7B $99.6B $88.5B
Revenue Growth (YoY) -2.43% 7.45% 26.95% 2.97% -11.13%
 
Cost of Revenues $59.2B $62.7B $78.4B $82.1B $73.1B
Gross Profit $11.7B $13.4B $18.3B $17.5B $15.4B
Gross Profit Margin 16.46% 17.65% 18.89% 17.52% 17.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.3B $1.2B $1.5B $1.1B $1.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $7.9B $8.3B $9.2B $9B $9.4B
Operating Income $3.8B $5.1B $9B $8.5B $6B
 
Net Interest Expenses $794.8M $778.9M $751.3M $531.5M $803.3M
EBT. Incl. Unusual Items $3.9B $4.8B $8.7B $8.3B $6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $781.4M $1.1B $2.3B $2.3B $1.7B
Net Income to Company $3.1B $3.6B $6.4B $6B $4.3B
 
Minority Interest in Earnings -$171.3M -$225M -$437.8M -$377.5M -$279.3M
Net Income to Common Excl Extra Items $2.9B $3.4B $6B $5.7B $4B
 
Basic EPS (Cont. Ops) $2.38 $2.75 $4.85 $4.65 $3.35
Diluted EPS (Cont. Ops) $2.34 $2.70 $4.74 $4.57 $3.29
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.2B $1.2B
 
EBITDA $8.8B $9.9B $13.8B $13.4B $11.7B
EBIT $4.7B $5.5B $9.4B $9B $6.9B
 
Revenue (Reported) $70.9B $76.2B $96.7B $99.6B $88.5B
Operating Income (Reported) $3.8B $5.1B $9B $8.5B $6B
Operating Income (Adjusted) $4.7B $5.5B $9.4B $9B $6.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $19B $23.6B $24.2B $21.1B $22.6B
Revenue Growth (YoY) 9.7% 24.53% 2.51% -12.78% 7.23%
 
Cost of Revenues $16.8B $20.7B $21.3B $19B $20.5B
Gross Profit $2.2B $2.9B $2.9B $2.1B $2.2B
Gross Profit Margin 11.39% 12.18% 11.84% 9.97% 9.55%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $550.8M $785.3M $817M $606.5M $707.2M
Operating Income $1.6B $2.1B $2.1B $1.5B $1.5B
 
Net Interest Expenses $196.5M $155.6M $125.9M $148.1M $231M
EBT. Incl. Unusual Items $1.4B $1.9B $1.9B $1.3B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $334.4M $538.8M $548M $395.2M $381.6M
Net Income to Company $1.1B $1.3B $1.2B $918.9M $928.9M
 
Minority Interest in Earnings -$66.7M -$100.2M -$113.8M -$43.6M -$66M
Net Income to Common Excl Extra Items $995.2M $1.3B $1.2B $878.7M $826M
 
Basic EPS (Cont. Ops) $0.81 $1.04 $1.02 $0.74 $0.70
Diluted EPS (Cont. Ops) $0.78 $1.03 $1.00 $0.74 $0.69
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.2B $1.2B
Weighted Average Diluted Share $1.3B $1.2B $1.2B $1.2B $1.2B
 
EBITDA $2.7B $3.3B $3.2B $2.8B $2.9B
EBIT $1.6B $2.1B $2.1B $1.6B $1.6B
 
Revenue (Reported) $19B $23.6B $24.2B $21.1B $22.6B
Operating Income (Reported) $1.6B $2.1B $2.1B $1.5B $1.5B
Operating Income (Adjusted) $1.6B $2.1B $2.1B $1.6B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $72.4B $92.6B $101.9B $89.8B $89.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $60.5B $74.9B $83.8B $74.5B $75.1B
Gross Profit $11.9B $17.6B $18.1B $15.3B $14.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $8B $8.9B $9B $8.6B $9.4B
Operating Income $3.9B $8.7B $9.1B $6.6B $5.3B
 
Net Interest Expenses $759.8M $799.7M $607.1M $661.5M $948.8M
EBT. Incl. Unusual Items $3.9B $8.5B $8.8B $6.3B $5.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $841.2M $2.3B $2.4B $1.8B $1.5B
Net Income to Company $3.2B $6B $6.3B $4.8B $3.8B
 
Minority Interest in Earnings -$213.5M -$364.6M -$458.9M -$242.4M -$289.4M
Net Income to Common Excl Extra Items $2.9B $5.8B $6B $4.3B $3.5B
 
Basic EPS (Cont. Ops) $2.31 $4.71 $4.90 $3.59 $2.97
Diluted EPS (Cont. Ops) $2.27 $4.62 $4.81 $3.53 $2.92
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $9B $13.7B $13.9B $11.7B $11.4B
EBIT $4.7B $9.1B $9.6B $7.1B $6.3B
 
Revenue (Reported) $72.4B $92.6B $101.9B $89.8B $89.9B
Operating Income (Reported) $3.9B $8.7B $9.1B $6.6B $5.3B
Operating Income (Adjusted) $4.7B $9.1B $9.6B $7.1B $6.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $53.6B $69.8B $75.2B $65.5B $66.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $48.4B $60.7B $66B $58.4B $60.4B
Gross Profit $5.2B $9.1B $9.1B $7.1B $6.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.9B $2.2B $2.2B $2B $2.1B
Operating Income $3.3B $6.9B $7B $5.1B $4.4B
 
Net Interest Expenses $499.6M $514.8M $372.7M $505.1M $651.5M
EBT. Incl. Unusual Items $2.7B $6.3B $6.5B $4.4B $3.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $651.9M $1.8B $1.9B $1.3B $1.1B
Net Income to Company $2.1B $4.5B $4.4B $3.1B $2.7B
 
Minority Interest in Earnings -$159.2M -$297.9M -$320.6M -$185.1M -$195.8M
Net Income to Common Excl Extra Items $1.9B $4.3B $4.3B $2.9B $2.4B
 
Basic EPS (Cont. Ops) $1.54 $3.46 $3.52 $2.45 $2.08
Diluted EPS (Cont. Ops) $1.52 $3.39 $3.46 $2.42 $2.04
Weighted Average Basic Share $3.7B $3.7B $3.7B $3.6B $3.5B
Weighted Average Diluted Share $3.8B $3.8B $3.7B $3.6B $3.6B
 
EBITDA $6.6B $10.4B $10.5B $8.8B $8.5B
EBIT $3.4B $7B $7.2B $5.3B $4.7B
 
Revenue (Reported) $53.6B $69.8B $75.2B $65.5B $66.9B
Operating Income (Reported) $3.3B $6.9B $7B $5.1B $4.4B
Operating Income (Adjusted) $3.4B $7B $7.2B $5.3B $4.7B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $3.2B $5.5B $1.8B $2B $2.3B
Short Term Investments $441.3M $1.6B $3.5B $24.7M $32.1M
Accounts Receivable, Net $8.8B $10.1B $12B $11.9B $10.6B
Inventory $438M $526.4M $659M $980.2M $1.2B
Prepaid Expenses $5.6M $13.5M $12.5M $1.4B $1.2B
Other Current Assets $2.9B $3.5B $4.1B $647.7M $332.7M
Total Current Assets $16.9B $22.5B $25.7B $23.9B $21.2B
 
Property Plant And Equipment $23.9B $27.1B $28.2B $30.8B $33.1B
Long-Term Investments -- -- -- -- --
Goodwill $12.7B $13.5B $12.9B $13.6B $14.5B
Other Intangibles $729.2M $811.8M $818.6M $1.5B $1.6B
Other Long-Term Assets $442.5M $196.8M $187.9M $242.4M $258.7M
Total Assets $58.4B $68B $72B $73.4B $73.9B
 
Accounts Payable $8.1B $9B $10.8B $10.7B $9.4B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $2.4B $2.2B $2.2B $2.4B $2.5B
Other Current Liabilities $1.1B $1.3B $1.5B $1B $600.2M
Total Current Liabilities $18.9B $21.4B $23.7B $23.9B $22.5B
 
Long-Term Debt $6B $8.5B $7.4B $6.5B $6.4B
Capital Leases -- -- -- -- --
Total Liabilities $42.3B $50.7B $49.9B $48B $48.6B
 
Common Stock $1.4B $1.5B $1.4B $1.3B $1.3B
Other Common Equity Adj -- -- -- -- --
Common Equity $15.8B $16.9B $21.6B $24.9B $24.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $308M $370.2M $523.1M $516.9M $456.5M
Total Equity $16.1B $17.3B $22.1B $25.4B $25.3B
 
Total Liabilities and Equity $58.4B $68B $72B $73.4B $73.9B
Cash and Short Terms $3.6B $7.1B $5.3B $2B $2.3B
Total Debt $6.6B $9.7B $8.2B $7.2B $7.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $5B $4.6B $4.1B $4.1B $3B
Short Term Investments $1B $2.3B $947.5M $450.9M $996.3M
Accounts Receivable, Net $9.9B $12.1B $13.2B $11B $11.9B
Inventory $544.8M $634.5M $952.4M $1.1B $1.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $3.2B $3.9B $3.7B $3.5B $3B
Total Current Assets $19.9B $23.8B $23.1B $20.7B $21.2B
 
Property Plant And Equipment $24.8B $27.4B $27.4B $31.3B $33.6B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $278.2M $1.2B $953.4M $530.3M $614.3M
Total Assets $62.6B $69.4B $68.2B $70.3B $74.7B
 
Accounts Payable $7.6B $9.3B $9.8B $8.6B $8.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $6B $7.2B $6.9B $6.8B $6.7B
Total Current Liabilities $19.5B $22.7B $22.5B $21.1B $23.3B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $46.9B $49B $44.7B $45.3B $49.4B
 
Common Stock $1.5B $1.4B $1.2B $1.3B $1.3B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $286.5M $410.6M $446.2M $380M $390.9M
Total Equity $15.7B $20.5B $23.4B $24.9B $25.3B
 
Total Liabilities and Equity $62.6B $69.4B $68.2B $70.3B $74.7B
Cash and Short Terms $6B $6.9B $5B $4.6B $4B
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.1B $3.6B $6.4B $6B $4.3B
Depreciation & Amoritzation $4.1B $4.4B $4.5B $4.4B $4.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$557.5M -$1.5B -$3.9B -$107.6M $2.3B
Change in Inventories $40.3M -$50.2M -$162.1M -$317.4M -$164.6M
Cash From Operations $6.8B $8.8B $11.8B $11.6B $10B
 
Capital Expenditures $4B $3.3B $4.4B $4.1B $3.7B
Cash Acquisitions $761.3M -$9.1M $14.2M -$1.6B -$412.5M
Cash From Investing -$2.4B -$4.2B -$5.7B -$3.4B -$2.4B
 
Dividends Paid (Ex Special Dividend) -$1.6B -$1.6B -$2B -$2.3B -$2.4B
Special Dividend Paid
Long-Term Debt Issued $390.7M -- -- -- --
Long-Term Debt Repaid -$2.5B -$2.8B -- -- --
Repurchase of Common Stock -$12.3M -$51.4M -$1.3B -$1.2B -$1.1B
Other Financing Activities -$78.4M $2.7B -$3.1B -$3.3B -$2.9B
Cash From Financing -$4.6B -$2.6B -$7.4B -$7.8B -$7.5B
 
Beginning Cash (CF) $3.4B $3.3B $5.3B $3.7B $4.1B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$227.3M $2.1B -$1.2B $395.5M $193.8M
Ending Cash (CF) $3.2B $5.1B $4.2B $4B $4B
 
Levered Free Cash Flow $2.7B $5.5B $7.4B $7.4B $6.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.1B $1.3B $1.2B $918.9M $928.9M
Depreciation & Amoritzation $1.2B $1.1B $947.6M $1.2B $1.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $56.2M -$740.4M $737.7M $441.6M $88.1M
Change in Inventories -$71M $39.9M -$184M -$31.4M $18.9M
Cash From Operations $3B $3B $3.2B $2.8B $2.3B
 
Capital Expenditures $781.7M $929.8M $814.5M $804.1M $560M
Cash Acquisitions -$612.7K -$26.1K -$48.8M $18.5M $42.2M
Cash From Investing -$478.7M -$1.3B -$1.3B -$607.9M -$548.9M
 
Dividends Paid (Ex Special Dividend) -$1.7B $43.7M $127.4M $3.6M -$50M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.9B -$2.2M $1M $545.5M $1.1B
Long-Term Debt Repaid -$735.4M -$597.7M -- -- --
Repurchase of Common Stock -$3.1M -$700.4M -$502.6M -$511.1M -$310.7M
Other Financing Activities -$2.9B -$49.5M -$435.8M -$1B -$2.1B
Cash From Financing -$2.6B -$1.6B -$1.4B -$1.5B -$1.9B
 
Beginning Cash (CF) $5B $4.7B $3.7B $3.6B $3.1B
Foreign Exchange Rate Adjustment -$113.9M $42.7M $47.2M $17.8M -$62.9M
Additions / Reductions -$102M $38.9M $570.7M $659.2M -$134.7M
Ending Cash (CF) $5B $4.6B $4.2B $4.3B $3B
 
Levered Free Cash Flow $2.2B $2.1B $2.4B $1.9B $1.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $3.2B $6B $6.3B $4.8B $3.8B
Depreciation & Amoritzation $4.5B $4.4B $4.2B $4.9B $5.1B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$473.8M -$3.2B -$2.4B $2.9B -$593.3M
Change in Inventories $25M -$80.4M -$347.8M -$171.9M -$29.8M
Cash From Operations $8.6B $11.9B $11.1B $11B $8.9B
 
Capital Expenditures $3B $4B $4.2B $4.3B $3.1B
Cash Acquisitions $21.3M $2.6M -$1.4B -$163.7M -$412.4M
Cash From Investing -$3.5B -$5B -$3.7B -$3.3B -$2.9B
 
Dividends Paid (Ex Special Dividend) -$1.7B -$1.9B -$2.2B -$2.5B -$2.4B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2.4B -$3.8B -- -- --
Repurchase of Common Stock -$52.7M -$1.1B -$1.1B -$1.2B -$1.2B
Other Financing Activities -$633.6M $3B -$5.6B -$3.2B -$2.8B
Cash From Financing -$2.5B -$7.4B -$7.4B -$7.4B -$7.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.6B -$497.5M -$22.1M $248M -$1.1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $5.6B $7.9B $6.9B $6.7B $5.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.1B $4.5B $4.4B $3.1B $2.7B
Depreciation & Amoritzation $3.4B $3.4B $3.1B $3.6B $3.8B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$604.6M -$2.3B -$846.2M $2.2B -$727M
Change in Inventories -$85.4M -$115.5M -$301.2M -$155.7M -$20.9M
Cash From Operations $5.6B $8.7B $7.9B $7.4B $6.2B
 
Capital Expenditures $1.9B $2.6B $2.3B $2.6B $2B
Cash Acquisitions -$10.5M $1.2M -$1.5B $8.7M $8.8M
Cash From Investing -$2.3B -$3.1B -$1.1B -$1.1B -$1.6B
 
Dividends Paid (Ex Special Dividend) -$1.7B -$2B -$2.2B -$2.4B -$2.4B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.9B $154.5M $1M $545.5M $1.1B
Long-Term Debt Repaid -$1.8B -$2.8B -- -- --
Repurchase of Common Stock -$52.6M -$1.1B -$856.3M -$907M -$1B
Other Financing Activities -$211.7M $60.1M -$2.4B -$2.3B -$2.2B
Cash From Financing -$1.4B -$6.3B -$6.3B -$6B -$5.6B
 
Beginning Cash (CF) $11B $16.2B $12.5B $13B $12B
Foreign Exchange Rate Adjustment -$178.9M $84.9M $123.9M -$230.8M -$73.7M
Additions / Reductions $1.8B -$720.4M $505.7M $358.2M -$981M
Ending Cash (CF) $12.9B $15.5B $12.7B $13.2B $11B
 
Levered Free Cash Flow $3.6B $6.1B $5.6B $4.8B $4.3B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock